Table 3 The prognosis of the groups
|  | CLV group (n = 75) | RALV group (n = 30) | χ2 | P value |
|---|---|---|---|---|
Status of homogeneous HPV infection |  |  | < 0.001 | > 0.999 |
 Negative | 69 (92.0) | 27 (90.0) |  |  |
 Positive | 6 (8.0) | 3 (10.0) |  |  |
Short-term prognosis | Â | Â | 0.434 | 0.805 |
 Regression | 71 (94.7) | 29 (96.7) |  |  |
 Remission | 3 (4.0) | 1 (3.3) |  |  |
 Persistence | 1 (1.3) | 0 |  |  |
Long-term prognosis | Â | Â | 1.259 | 0.533 |
 Disease-free | 70 (93.3) | 29 (96.7) |  |  |
 Recurrence | 2 (2.7) | 1 (3.3) |  |  |
 Progression | 3 (4.0) | 0 |  |  |